Iatrogenic osteomalacia: Report of two cases

Journal of UOEH

Volumn 35, Issue 1, 2013, Pages 25-31

  Yamamoto, Sunao ^a   Okada, Yosuke ^a   Mori, Hiroko ^a   Kurozumi, Akira ^a   Torimoto, Keiichi ^a   Arao, Tadashi ^a   Tanaka, Yoshiya ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Fibroblast growth factor 23; Gastrectomy; Osteomalacia; Saccharated ferric oxide

Indexed keywords

FERRIC ION; FERRIC OXIDE, SACCHARATED; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 23; SACCHARIC ACID;

ARTICLE; BLOOD; CASE REPORT; CHEMICALLY INDUCED DISORDER; FEMALE; GASTRECTOMY; HUMAN; IATROGENIC DISEASE; IRON DEFICIENCY ANEMIA; MALE; MIDDLE AGED; OSTEOMALACIA; POSTOPERATIVE COMPLICATION; VERY ELDERLY; VITAMIN D DEFICIENCY;

AGED, 80 AND OVER; ANEMIA, IRON-DEFICIENCY; FEMALE; FERRIC COMPOUNDS; FIBROBLAST GROWTH FACTORS; GASTRECTOMY; GLUCARIC ACID; HUMANS; HYPOPHOSPHATASIA; IATROGENIC DISEASE; MALE; MIDDLE AGED; OSTEOMALACIA; POSTOPERATIVE COMPLICATIONS; VITAMIN D DEFICIENCY;

MLCS; MLOWN;

EID: 84880300495     PISSN: 0387821X     EISSN: None     Source Type: Journal    
DOI: 10.7888/juoeh.35.25     Document Type: Article

References (21)

1. Bringhurst FR, Demay MB, Krane SM & Kronenberg HM (2008): Bone and mineral metabolism in health and disease. In: Harrison's principles of internal medicine, 17th. Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL & Jameson JL ed. McGraw-Hill, New York pp 2365-2377
2. Okada M, Imamura K, Iida M, Fuchigami T & Omae T (1983): Hypophosphatemia induced by intravenous administration of Saccharated iron oxide. Klin Wochen-schr 61: 99-102
3. Sato K & Shiraki M (1998): Saccharated ferric oxide-induced osteomalacia in Japan: iron-induced osteopathy due to nephropathy. Endocr J 45: 431-439
4. Bisballe S, Eriksen EF, Melsen F, Mosekilde L, Sorensen OH & Hessov I (1991): Osteopenia and osteomalacia after gastrectomy: interrelations between biochemical markers of bone remodelling, vitamin D metabolites, and bone histomorphometry. Gut 32: 1303-1307
5. Schouten BJ, Hunt PJ, Livesey JH, Frampton CM & Soule SG (2009): FGF23 elevation and hypophosphatemia after intravenous iron polymaltose: a prospective study. J Clin Endocrinol Metab 94: 2332-2337
6. Shimizu Y, Tada Y, Yamauchi M, Okamoto T, SuzukiH, Ito N, Fukumoto S, Sugimoto T & Fujita T (2009): Hypophosphatemia induced by intravenous administration of saccharated ferric oxide: another form of FGF23-related hypophosphatemia. Bone 45: 814-816
7. Shimada T, Hasegawa H, Yamazaki Y, Muto T, Hino R, Takeuchi Y, Fujita T, Nakahara K, Fukumoto S & Yamashita T (2004): FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 19: 429-435
8. Hori M, Shimizu Y & Fukumoto S (2011): Minireview: fibroblast growth factor 23 in phosphate homeostasis and bone metabolism. Endocrinology 152: 4-10
9. Imamura K (1984): Effects of intravenous administration of iron preparations on the metabolism of phosphorus. Comparative study on 3 iron preparations. Fukuo-ka Igaku Zasshi 75: 316-326
10. Tovey FI, Godfrey JE & Lewin MR (1990): A gastrectomy population: 25-30 years on. Postgrad Med J 66: 450-456
11. Morgan DB, Hunt G & Paterson CR (1970): The osteomalacia syndrome after stomach operations. Q J Med 39:395-410
12. Nilas L, Christiansen C & Christiansen J (1985): Regulation of vitamin D and calcium metabolism after gastrectomy. Gut 26: 252-257
13. Uno H, Izawa Y, Sagara K, Koyama T, Makita T, Chang C & Sugiyama M (1990): Effect of 1 a-hydroxyvitamin D3 on bone metabolic disorders in gastrectomized rats. J Bone Miner Metab 8: 10-16
14. Kikuchi M (2003): The influence of post total gastrectomy on calcium metabolism and the effects of vitamin K2 (Menatetrenone) on both the post-operative lower bone mineral density and bone strength in rats. Jpn J Surg Metab Nutr 37: 225-237 (in Japanese)
15. American Gastroenterological Association (2003): American Gastroenterological Association medical position statement: guidelines on osteoporosis in gastrointestinal diseases. Gastroenterology 124: 791-794
16. Bernstein CN, Leslie WD & Leboff MS (2003): AGA technical review on osteoporosis in gastrointestinal diseases. Gastroenterology 124: 795-841
17. Sugiyama M, Kunisaki C, Kato H, Imada T, Shimada H, Hirata K, Kosaka T, Yoshida M, Kitajima M & Aiko T (2011): Utility of Alendronate in Metabolic Bone Diseases after Gastrectomy. Jpn J Gastroenterol Surg 44: 361-373 (in Japanese)
18. Zittel TT, Zeeb B, Maier GW, Kaiser GW, Zwirner M, Liebich H, Starlinger M & Becker HD (1997): High prevalence of bone disorders after gastrectomy. Am J Surg 174:431-438
19. Steinbrook R (2004): Surgery for severe obesity. N EnglJMed350: 1075-1079
20. Coates PS, Fernstrom JD, Fernstrom MH, Schauer PR & Greenspan SL (2004): Gastric bypass surgery for morbid obesity leads to an increase in bone turnover and a decrease in bone mass. J Clin Endocrinol Metab 89:1061-1065
21. Fleischer J, Stein EM, Bessler M, Delia Badia M, Restuccia N, Olivero-Rivera L, McMahon DJ & Silverberg SJ (2008): The decline in hip bone density after gastric bypass surgery is associated with extent of weight loss. J Clin Endocrinol Metab 93: 3735-3740